Immitra Bio, a Zürich-based #genetic #medicine platform bringing scalability and commercial viability to #gene #editing #therapies, has announced the completion of an upsized €2.58 million pre-Seed #financing round. 🇨🇭🧬🔬

https://t.co/DWrgg6MlsQ
1
You’ve reached the end 🎉